1pi2: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:1pi2.png|left|200px]] | [[Image:1pi2.png|left|200px]] | ||
{{STRUCTURE_1pi2| PDB=1pi2 | SCENE= }} | {{STRUCTURE_1pi2| PDB=1pi2 | SCENE= }} | ||
===REACTIVE SITES OF AN ANTICARCINOGENIC BOWMAN-BIRK PROTEINASE INHIBITOR ARE SIMILAR TO OTHER TRYPSIN INHIBITORS=== | ===REACTIVE SITES OF AN ANTICARCINOGENIC BOWMAN-BIRK PROTEINASE INHIBITOR ARE SIMILAR TO OTHER TRYPSIN INHIBITORS=== | ||
{{ABSTRACT_PUBMED_1730730}} | {{ABSTRACT_PUBMED_1730730}} | ||
==About this Structure== | ==About this Structure== | ||
[[1pi2]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Glycine_max Glycine max]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1PI2 OCA]. | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:001730730</ref><references group="xtra"/> | ||
[[Category: Glycine max]] | [[Category: Glycine max]] | ||
[[Category: Chen, P.]] | [[Category: Chen, P.]] | ||
Line 29: | Line 17: | ||
[[Category: Wang, B C.]] | [[Category: Wang, B C.]] | ||
[[Category: Serine proteinase inhibitor]] | [[Category: Serine proteinase inhibitor]] | ||